Fink, Mitchell P.

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences

Sepsis Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 1,126

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine

Advanced Glycation End Products researchOrgan Transplantation Techniques and Outcomes

Cited by 1,113

Animal models of sepsis

Fink, M. P. (2014) · Virulence

Sepsis Diagnosis and TreatmentInflammation biomarkers and pathways

Cited by 391

Nitro-fatty Acid Reaction with Glutathione and Cysteine

Baker, L. M. S., Baker, P. R. S., Golin-Bisello, F., Schopfer, F. J., Fink, M., Woodcock, S. R., Branchaud, B. P., Radi, R., & Freeman, B. A. (2007) · Journal of Biological Chemistry

Redox biology and oxidative stressAntioxidant Activity and Oxidative Stress

Cited by 200

Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients*

Milbrandt, E. B., Kersten, A., Kong, L., Weissfeld, L. A., Clermont, G., Fink, M. P., & Angus, D. C. (2005) · Critical Care Medicine

Intensive Care Unit Cognitive DisordersRespiratory Support and Mechanisms

Cited by 140

Cutting Edge: High-Mobility Group Box 1 Preconditioning Protects against Liver Ischemia-Reperfusion Injury

Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N. D., Li, J., Tracey, K. J., Demarco, R. A., Lotze, M. T., Fink, M. P., Geller, D. A., et al. (2006) · The Journal of Immunology

Advanced Glycation End Products researchOrgan Transplantation Techniques and Outcomes

Cited by 116